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VITAMIN D AND FALLS AND FRACTURES IN OLDER WOMEN
Y. Fernandez1, R. Batra1, D. Prieto-Alhambra2, T. Spector3, K. Javaid1,
N. Arden1,4. 1NIHR Musculoskeletal BRU. Univ. of Oxford, Oxford, United
Kingdom; 2Univ.t Autonoma de Barcelona, Departament de Med., Barcelona,
Spain; 3Dept. of Twin Res. and Genetic Epidemiology, King’s Coll. London.,
London, United Kingdom; 4MRC Environmental Epidemiology Unit,
Southampton Gen. Hosp., Southampton, United Kingdom
Purpose: The effect of vitamin D status on falls is not consistent. We
aimed to assess the existing relationship between vitamin D, measured
by 25-hydroxyvitamin D plasma concentrations and the occurrence of
falls and fractures.
Methods: Design, participants and setting: Prospective population-based
longitudinal study involving 775 women aged 43–67 from a general
practice in Chingford, North-East London followed prospectively for
12 years.
Measurements: Falls and fractures were assessed by standardized,
nurse-administered questionnaires. 25-hydroxy-vitamin D serum
concentrations (25-OH-D) were determined by Radioimmunoassay (RIA)
and analysed as a continuous variable. Vitamin D levels were treated
as a categorical variable with 3 levels (Deﬁcient (<20ng/ml), Insufﬁcient
(20–29ng/ml) and Sufﬁcient (≥30ng/ml)).
Statistics: The associations between 25-OH-D and falls and fractures were
assessed using multivariate Cox-proportional hazards regression models.
These were adjusted for age, BMI, age at menopause, HRT status and
vitamin D and Calcium supplements. In order to test for interactions
between 25-OH-D and season; multiplicative terms were introduced in
the model.
Results: 775 women (mean age 57.15 years) had 25-OH-D levels available
and were included in the study. 215 (27.7%) had deﬁcient vitamin D levels
(<20ng/mL), 330(42.6%) were insufﬁcient (20–29ng/mL) and 230 (29.7%)
had sufﬁcient vitamin D levels (≥30ng/mL).
An increase of 10ng/ml of 25-OH-D led to an 11% (95%CI 0.80, 0.99)
decreased risk of falls (p = 0.025). After adjusting for other explanatory
variables (age, BMI, HRT use and age at menopause), this remained
signiﬁcant. After adjusting further for supplement use, the effect of
vitamin D did not change (p =0.041) and interaction terms between
25-OH-D and season were not signiﬁcant (p = 0.65).
In contrast, the results of Cox regression showed no association between
25-OH-D and risk of fractures. After adjusting for other explanatory
variables (age, BMI, age at menopause, HRT status and supplements),
these results did not change.
Conclusions: In this observational population-based study, low serum
vitamin D levels are associated with an increased risk of falls in post-
menopausal Caucasian women. No association with incident fractures
could be demonstrated.
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GENE EXPRESSION PROFILING OF CARTILAGE DEGRADATION IN
A MOUSE MODEL OF OSTEOARTHRITIS IDENTIFIES SIGNIFICANT
ALTERATION IN KEY MOLECULAR PROCESSES
M.D. Gardiner, A. Chanalaris, H. Nagase. Imperial Coll. London, London,
United Kingdom
Purpose: Proﬁling the changes in chondrocyte gene expression during
the initiation and progression of osteoarthritis (OA) identiﬁes key early
events in the disease pathogenesis. Studying OA progression using human
cartilage is challenging owing to the difﬁculty in acquiring tissue. The
surgically induced destabilisation of the medial meniscus (DMM) mouse
model provides genetically homogenous cartilage at any disease stage.
Comparison of diseased and control cartilage provides an insight into
the molecular changes occurring in early OA.
Methods: The DMM mouse model of OA was used to study chondrocyte
whole genome expression changes in mouse knee articular cartilage at
2, 4 and 8 weeks following surgery. Histological sections were used
to assess the cartilage degradation. A new microdissection technique
enabled targeted collection of pure mouse articular cartilage from
the medial tibial plateau. RNA isolated from OA and control joint
cartilage was pooled and ampliﬁed using NuGEN Ovation Pico before
hybridization to Illumina Mouse WG-6 v2.0 Expression BeadChips. Two-
way ANOVA was performed to investigate the interaction of time and
disease. Functional annotation clustering (FAC) and pathway analysis
were performed using DAVID. A selection of genes was validated using
real-time RT-PCR.
Results: In OA cartilage at 2 weeks there was signiﬁcantly increased
expression of metallopeptidases, including Mmp2, Mmp3, Mmp13,
Mmp14, Adamts4 and Adamts12; only Mmp2 and Mmp3 remained
increased at 4 and 8 weeks. Adamts5 expression was not detected.
In addition, many serpin serine protease inhibitors were signiﬁcantly
decreased, which is likely to further promote matrix catabolism. There
was a strong anabolic response at 2 weeks with increased expression
of many minor collagens and small leucine-rich repeat proteoglycans
(SLRPs). Fibromodulin was strongly increased in OA cartilage at all time
points. Cytoskeletal organisation genes were signiﬁcantly decreased in
expression at 2 and 4 weeks but not 8 weeks. In addition, genes
involved in promoting apoptosis, were signiﬁcantly decreased. Genes not
previously identiﬁed as expressed by chondrocytes included tenascin-W,
which was signiﬁcantly increased in OA cartilage at all time points.
Myeloperoxidase was unaltered at 2 weeks but strongly increased at
4 weeks in OA cartilage.
Conclusions: Application of a new microdissection technique enabled
gene expression analysis of pure mouse articular cartilage during OA
progression. This technique can be used to isolate other joint tissues.
In OA cartilage we identiﬁed an early increase in metalloproteinase
gene expression without increase in tissue inhibitors and signiﬁcant
dysregulation of cytoskeletal genes. Gene expression changes also
appeared to promote cell survival. The strong increase in tenascin-W
warrants further investigation.
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A GENOME WIDE ASSOCIATION STUDY ON JOINT SPACE WIDTH
IDENTIFIES A NEW GENE INVOLVED IN CARTILAGE THICKNESS AND
OSTEOARTHRITIS
M.C. Castano Betancourt1,2, A. Valdes3, F. Cornelis4, H. Kerkhof1,2,
S. Doherty5, M. Wheeler5, W. Zhang5, R. Maciewicz6, K. Muir7,
D. Hart3, S. Metrustry3, M. Mangino3, N. Arden8, F. Cailotto4,
M. Peters1,2, F. Rivadeneira1,2, A. Hofman1, A.G. Uitterlinden1,2,
M. Doherty5, T. Spector3, R. Lories4, J.B. van Meurs1,2. 1Dept. of Internal
Med., ErasmusMC, Rotterdam, Netherlands; 2Netherlands Genomics
Initiative-Sponsored by the Netherlands Consortium for Hlth.y Aging,
Rotterdam, Leiden, Netherlands; 3Dept of Twin Res. and Gen Epidemiology,
St. Thomas’ Hosp., King’s Coll. London, London, United Kingdom; 4Lab. for
Skeletal Dev. and Joint Disorders, KU Leuven, Leuven, Belgium; 5Univ. of
Nottingham, Nottingham, United Kingdom; 6Astra Zeneca, London, United
Kingdom; 7Univ. of Warwick, Coventry, United Kingdom; 8Univ. of Oxford,
Oxford, United Kingdom
Purpose: To identify new genes involved in osteoarthritis (OA) by
performing a genome wide association study (GWAS) on cartilage
thickness.
Methods: We performed a GWAS on radiographically measured minimal
joint space width (mJSW) of the hip in 6523 participants from the
Rotterdam Study I and II. The top signal was replicated in a total of 4443
individuals from 3 studies in the UK: Chingford, GOAL and TwinsUK.
We assessed the risk for hip OA in 3212 cases and 9869 controls
combining data from 6 study populations. Immunohistochemical staining
was performed on the identiﬁed gene during mouse limb development,
and in mature healthy and OA mouse joints
Results: The GWAS on mJSW identiﬁed a SNP on chromosome 19 to
be associated with larger joint space width (P =4.8×10−10, beta 0.09,
95% CI 0.06–0.12). The association was replicated in the 3 UK-cohorts
for an overall meta-analysis P value of 1.1×10−11 (beta: 0.09, 95% CI
0.06–0.11). The minor allele for larger joint space was also associated
with decreased risk for hip OA (OR 0.88, 95%CI 0.82–0.93, p = 7×10−5).
The SNP was consistently associated with mJSW in individuals without
hipOA, suggesting that the effect is on cartilage thickness rather then
degradation.
The SNP is located in a gene that has recently been linked to
wnt-signalling, and our results now suggest a role in chondrogenic
differentiation. We observed nuclear staining of mature chondrocytes
and the developing muscle in the developmental limb bud, but much
lower expression in the joint interzone. Postnatal joints show clear
expression in the growth plate and cartilage. When mouse knee joints
